vs
Alignment Healthcare, Inc.（ALHC）与CLOVER HEALTH INVESTMENTS, CORP.（CLOV）财务数据对比。点击上方公司名可切换其他公司
Alignment Healthcare, Inc.的季度营收约是CLOVER HEALTH INVESTMENTS, CORP.的2.1倍（$1.0B vs $487.7M）。Alignment Healthcare, Inc.净利率更高（-1.1% vs -10.1%，领先9.0%）。CLOVER HEALTH INVESTMENTS, CORP.同比增速更快（44.7% vs 44.4%）。Alignment Healthcare, Inc.自由现金流更多（$-55.4M vs $-68.7M）。过去两年Alignment Healthcare, Inc.的营收复合增速更高（26.9% vs 18.6%）
Alignment Healthcare是总部位于美国的医疗保健企业，主打联邦医疗保险优势计划，为老年群体提供协调医疗服务、处方药保障及补充福利，采用价值导向医疗模式，与本土医疗机构合作，业务覆盖美国多个州，致力提升患者健康水平。
克利弗健康投资公司是2014年成立的美国医疗保健企业，主营联邦医疗保险优势计划保险产品，是与美国政府直接签约合作的机构。目前公司为美国11个州的联邦医疗保险参保人提供健康管理服务，并已于2021年1月8日公开上市。
ALHC vs CLOV — 直观对比
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $487.7M |
| 净利润 | $-11.0M | $-49.3M |
| 毛利率 | — | — |
| 营业利润率 | -1.0% | -10.1% |
| 净利率 | -1.1% | -10.1% |
| 营收同比 | 44.4% | 44.7% |
| 净利润同比 | 64.6% | -123.2% |
| 每股收益（稀释后） | $-0.04 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $1.0B | $487.7M | ||
| Q3 25 | $993.7M | $496.6M | ||
| Q2 25 | $1.0B | $477.6M | ||
| Q1 25 | $926.9M | $462.3M | ||
| Q4 24 | $701.2M | $337.0M | ||
| Q3 24 | $692.4M | $331.0M | ||
| Q2 24 | $681.3M | $356.3M | ||
| Q1 24 | $628.6M | $346.9M |
| Q4 25 | $-11.0M | $-49.3M | ||
| Q3 25 | $3.7M | $-24.4M | ||
| Q2 25 | $15.7M | $-10.6M | ||
| Q1 25 | $-9.1M | $-1.3M | ||
| Q4 24 | $-31.1M | $-22.1M | ||
| Q3 24 | $-26.4M | $-9.2M | ||
| Q2 24 | $-24.0M | $7.4M | ||
| Q1 24 | $-46.5M | $-19.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 24.5% | ||
| Q2 24 | — | 30.3% | ||
| Q1 24 | — | 23.6% |
| Q4 25 | -1.0% | -10.1% | ||
| Q3 25 | 0.8% | -4.9% | ||
| Q2 25 | 2.2% | -2.2% | ||
| Q1 25 | -0.6% | -0.3% | ||
| Q4 24 | -3.2% | -6.4% | ||
| Q3 24 | -2.8% | -2.7% | ||
| Q2 24 | -2.7% | 2.0% | ||
| Q1 24 | -6.5% | -6.5% |
| Q4 25 | -1.1% | -10.1% | ||
| Q3 25 | 0.4% | -4.9% | ||
| Q2 25 | 1.5% | -2.2% | ||
| Q1 25 | -1.0% | -0.3% | ||
| Q4 24 | -4.4% | -6.6% | ||
| Q3 24 | -3.8% | -2.8% | ||
| Q2 24 | -3.5% | 2.1% | ||
| Q1 24 | -7.4% | -5.5% |
| Q4 25 | $-0.04 | — | ||
| Q3 25 | $0.02 | — | ||
| Q2 25 | $0.07 | — | ||
| Q1 25 | $-0.05 | — | ||
| Q4 24 | $-0.15 | — | ||
| Q3 24 | $-0.14 | — | ||
| Q2 24 | $-0.13 | — | ||
| Q1 24 | $-0.25 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $604.2M | $78.3M |
| 总债务越低越好 | $323.2M | — |
| 股东权益账面价值 | $179.3M | $308.7M |
| 总资产 | $1.1B | $541.0M |
| 负债/权益比越低杠杆越低 | 1.80× | — |
8季度趋势，按日历期对齐
| Q4 25 | $604.2M | $78.3M | ||
| Q3 25 | $644.1M | — | ||
| Q2 25 | $503.8M | — | ||
| Q1 25 | $479.5M | — | ||
| Q4 24 | $470.6M | $194.5M | ||
| Q3 24 | $381.0M | $288.0M | ||
| Q2 24 | $363.7M | $254.8M | ||
| Q1 24 | $301.7M | $208.3M |
| Q4 25 | $323.2M | — | ||
| Q3 25 | $322.7M | — | ||
| Q2 25 | $322.3M | — | ||
| Q1 25 | $321.9M | — | ||
| Q4 24 | $321.4M | — | ||
| Q3 24 | $212.0M | — | ||
| Q2 24 | $211.7M | — | ||
| Q1 24 | $162.0M | — |
| Q4 25 | $179.3M | $308.7M | ||
| Q3 25 | $161.9M | $340.9M | ||
| Q2 25 | $141.0M | $344.2M | ||
| Q1 25 | $108.1M | $336.1M | ||
| Q4 24 | $99.9M | $341.1M | ||
| Q3 24 | $114.5M | $342.2M | ||
| Q2 24 | $123.7M | $324.9M | ||
| Q1 24 | $130.9M | $292.5M |
| Q4 25 | $1.1B | $541.0M | ||
| Q3 25 | $1.1B | $559.7M | ||
| Q2 25 | $1.0B | $575.0M | ||
| Q1 25 | $895.6M | $583.7M | ||
| Q4 24 | $782.1M | $580.7M | ||
| Q3 24 | $692.3M | $653.0M | ||
| Q2 24 | $716.3M | $674.2M | ||
| Q1 24 | $633.2M | $671.8M |
| Q4 25 | 1.80× | — | ||
| Q3 25 | 1.99× | — | ||
| Q2 25 | 2.29× | — | ||
| Q1 25 | 2.98× | — | ||
| Q4 24 | 3.22× | — | ||
| Q3 24 | 1.85× | — | ||
| Q2 24 | 1.71× | — | ||
| Q1 24 | 1.24× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-50.4M | $-68.2M |
| 自由现金流经营现金流 - 资本支出 | $-55.4M | $-68.7M |
| 自由现金流率自由现金流/营收 | -5.5% | -14.1% |
| 资本支出强度资本支出/营收 | 0.5% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $113.1M | $-69.0M |
8季度趋势，按日历期对齐
| Q4 25 | $-50.4M | $-68.2M | ||
| Q3 25 | $144.6M | $12.1M | ||
| Q2 25 | $29.1M | $5.4M | ||
| Q1 25 | $16.6M | $-16.3M | ||
| Q4 24 | $-8.7M | $-85.8M | ||
| Q3 24 | $26.2M | $50.0M | ||
| Q2 24 | $23.5M | $44.8M | ||
| Q1 24 | $-6.2M | $25.9M |
| Q4 25 | $-55.4M | $-68.7M | ||
| Q3 25 | $139.1M | $11.4M | ||
| Q2 25 | $21.1M | $4.8M | ||
| Q1 25 | $8.4M | $-16.5M | ||
| Q4 24 | $-18.0M | $-86.1M | ||
| Q3 24 | $16.9M | $49.6M | ||
| Q2 24 | $11.8M | $44.4M | ||
| Q1 24 | $-17.4M | $25.5M |
| Q4 25 | -5.5% | -14.1% | ||
| Q3 25 | 14.0% | 2.3% | ||
| Q2 25 | 2.1% | 1.0% | ||
| Q1 25 | 0.9% | -3.6% | ||
| Q4 24 | -2.6% | -25.6% | ||
| Q3 24 | 2.4% | 15.0% | ||
| Q2 24 | 1.7% | 12.5% | ||
| Q1 24 | -2.8% | 7.3% |
| Q4 25 | 0.5% | 0.1% | ||
| Q3 25 | 0.6% | 0.1% | ||
| Q2 25 | 0.8% | 0.1% | ||
| Q1 25 | 0.9% | 0.0% | ||
| Q4 24 | 1.3% | 0.1% | ||
| Q3 24 | 1.3% | 0.1% | ||
| Q2 24 | 1.7% | 0.1% | ||
| Q1 24 | 1.8% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | 38.77× | — | ||
| Q2 25 | 1.86× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 6.04× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
